CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
6 hedge funds and large institutions have $1.86M invested in Loncar China BioPharma ETF in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$1.37M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$36K |
Top Sellers
| 1 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
-$23.4K |
| 2 |
MCM
MV Capital Management
Bethesda,
Maryland
|
-$19K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$3.44K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $1.37M | +$1.37M | +36,836 | New |
|
|
FEM
2
Fulcrum Equity Management
Plano,
Texas
| $340K | -$23.4K | -629 | -6% |
|
3
Morgan Stanley
New York
| $82K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $36K | +$36K | +954 | New |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| $31K | -$3.44K | -92 | -10% |
|
|
MCM
6
MV Capital Management
Bethesda,
Maryland
| – | -$19K | -400 | Closed |
|